AU2001246846A1 - Immunoassay of anti-hm1.24 antibody - Google Patents
Immunoassay of anti-hm1.24 antibodyInfo
- Publication number
- AU2001246846A1 AU2001246846A1 AU2001246846A AU4684601A AU2001246846A1 AU 2001246846 A1 AU2001246846 A1 AU 2001246846A1 AU 2001246846 A AU2001246846 A AU 2001246846A AU 4684601 A AU4684601 A AU 4684601A AU 2001246846 A1 AU2001246846 A1 AU 2001246846A1
- Authority
- AU
- Australia
- Prior art keywords
- immunoassay
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003018 immunoassay Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-105423 | 2000-04-06 | ||
| JP2000105423 | 2000-04-06 | ||
| PCT/JP2001/002964 WO2001077362A1 (en) | 2000-04-06 | 2001-04-05 | Immunoassay of anti-hm1.24 antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001246846A1 true AU2001246846A1 (en) | 2001-10-23 |
Family
ID=18618782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001246846A Abandoned AU2001246846A1 (en) | 2000-04-06 | 2001-04-05 | Immunoassay of anti-hm1.24 antibody |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001246846A1 (en) |
| WO (1) | WO2001077362A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1559432B1 (en) | 2002-10-30 | 2009-08-12 | Chugai Seiyaku Kabushiki Kaisha | Hm1.24-utilizing cancer vaccines |
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| EP2500413A1 (en) | 2006-09-13 | 2012-09-19 | Abbott Laboratories | Cell culture improvements |
| EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
| WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
| BR112015004467A2 (en) | 2012-09-02 | 2017-03-21 | Abbvie Inc | method for controlling protein heterogeneity |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| CA2905010A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| CN108295242B (en) * | 2016-06-28 | 2021-06-18 | 深圳宾德生物技术有限公司 | Pharmaceutical composition for preventing and/or treating psoriasis and application of CD317 extracellular domain protein |
| CN112462071B (en) * | 2020-11-13 | 2023-02-07 | 北京元恩生物技术有限公司 | Special enzyme-linked immunoassay kit for ribavirin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW442493B (en) * | 1993-10-15 | 2001-06-23 | Toshio Hirano | A membrane protein polypeptide having pre-B cell growth-supporting ability and a gene thereof |
| UA76934C2 (en) * | 1996-10-04 | 2006-10-16 | Chugai Pharmaceutical Co Ltd | Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody |
| JP3992298B2 (en) * | 1997-10-03 | 2007-10-17 | 中外製薬株式会社 | Natural humanized antibody |
| EP1757941B1 (en) * | 1998-02-25 | 2010-03-31 | Chugai Seiyaku Kabushiki Kaisha | Method for immunochemically assaying anti-hm1.24 antibody |
-
2001
- 2001-04-05 AU AU2001246846A patent/AU2001246846A1/en not_active Abandoned
- 2001-04-05 WO PCT/JP2001/002964 patent/WO2001077362A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001077362A1 (en) | 2001-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001246846A1 (en) | Immunoassay of anti-hm1.24 antibody | |
| AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
| AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
| AU2002210918A1 (en) | Degraded agonist antibody | |
| AU2001234125A1 (en) | Antibody library | |
| AU1290001A (en) | Antibodies | |
| AU2002256895A1 (en) | Anti-TRAIL-R antibodies | |
| AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
| GB9809839D0 (en) | Antibody | |
| AU2001240819A1 (en) | Proteomics database | |
| AU2002222112A1 (en) | Hybrid antibodies | |
| AU2001282890A1 (en) | Immunosensor | |
| AU2002210917A1 (en) | Degraded TPO agonist antibody | |
| AU4935000A (en) | Antibodies | |
| AU1687500A (en) | Antihuman vegf monoclonal antibody | |
| AU2002365649A1 (en) | Anti-dota antibody | |
| IL147517A0 (en) | Monoclonal antibodies and immunoassay utilizing the same | |
| AU7072998A (en) | Immunoassays using anti-allotypic monoclonal antibodies | |
| AU2759899A (en) | Purified sperm surface antigen, monoclonal antibody therefor and application therefor | |
| AU2596397A (en) | Monoclonal antibody that detects apoptotic antigen | |
| AU2002221132A1 (en) | Novel antibody | |
| AU2452301A (en) | Protein methylarginine-specific antibodies | |
| AU2001267922A1 (en) | Method of assaying the function of fc fragment of antibody | |
| AU2001284899A1 (en) | Methods and universal monoclonal antibody array | |
| GB9828700D0 (en) | Antibody |